Flavanones

Flavanones has been studied in 23 papers since 2015: 19 observational studies in people, 4 reviews; 7 in the past year. It has not reached trials in people. The newest paper, Sep 17, 2026: “Dietary (Poly)phenol Intake, Inflammatory Biomarkers, and Mild Cognitive Impairment in Italian Adults”.

InterventionPreclinical

23 papers study it11 findingsUpdated

MeSH

Research on it is growing 10% slower than aging research as a whole: 13 papers in the latest year counted

1 new paper in 30 daysSee all 23 papers on flavanones

At a glance

Higher flavanone intake is linked with lower stroke risk and less cognitive decline in women in human observational studies; independent labs report the stroke association. Reviews describe lower cardiovascular risk and systolic blood pressure. A paper declares company ties.

11 findings in 9 papers from 2015 to 2026, 3 of them since August 2026

Independent labs found the same change in people. 9 independent labs in 6 countries.

“with HRs (95% CIs) for quintile 5 vs. corresponding quintile being 0.63 (0.55 to 0.71) and 0.84 (0.95 to 0.94)”
Association of Dietary Flavonoid Intake with Incident Depression Risk and Brain Structural Changes: A Prospective Study in the UK BiobankmedRxiv2025doi:10.1101/2025.11.07.25339744

None of its findings points the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 9 independent labs in 6 countries
  • Funders: European Commission and others
  • 1 of 11 findings with company ties
  • Humans19

What did studies of flavanones find?

2

Studies of flavanones measured 2 outcomes: systolic blood pressure and cognitive decline.

Systolic blood pressure

downin humans1

1 study
  1. Flavanones decrease systolic blood pressure in humans.

    “Intervention studies demonstrated favorable effects on total cholesterol, LDL cholesterol, systolic blood pressure, fasting glucose, and C-reactive protein concentrations”

    Review

    Flavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies

    Epidemiologia (Basel, Switzerland)

Cognitive decline

downin humans1

1 study
  1. Flavanones are linked with less cognitive decline in humans (T3-T1=0.45, 95% CI 0.13, 0.77, p=0.01).

    “Higher intakes of flavanones (tertile (T)3-T1=0.45, 95%CI 0.13,0.77; p=0.01) and anthocyanins (T3-T1=0.45, 95%CI 0.08,0.81; p=0.02) were associated with improvements in age-related cognition score over 10 years.”

    Humans10 yearsfemalesn = 224

    Increased habitual flavonoid intake predicts attenuation of cognitive ageing in twins

    BMC medicine

What is flavanones linked with?

8

Studies link flavanones with 8 measures, among them stroke, cognitive function and cardiovascular disease.

Stroke

downin humans2OR 0.49

2 studies
  1. Flavanones are linked with a lower risk of stroke in humans (OR = 0.49; 95% CI: 0.30, 0.82).

    “higher flavanone intake was significantly associated with a lower stroke prevalence in females (Q4 vs 1: OR = 0.49; 95% CI: 0.30, 0.82; p for trend = 0.04).”

    Humansfemales

    Association between dietary flavonoid intake and stroke in Adults: The National Health and Nutrition Examination Survey 2007-2010 and 2017-2018

    Medicine

  2. Flavanones lower the risk of stroke in humans (relative risk reductions ranging from 12% to 26%).

    “stroke (relative risk reductions ranging from 12% to 26%)”

    Review

    Flavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies

    Epidemiologia (Basel, Switzerland)

More on Stroke

Cognitive function

upin humans1

1 study
  1. Flavanones are associated with cognitive function in humans.

    “Higher intakes of flavanones, flavones, lignans, hesperetin, naringenin, lariciresinol, matairesinol, and pinoresinol were positively associated with cognitive performance.”

    Humans

    Dietary (Poly)phenol Intake, Inflammatory Biomarkers, and Mild Cognitive Impairment in Italian Adults

    Antioxidants (Basel, Switzerland)

Cardiovascular disease

downin humans1

1 study
  1. Flavanones lower the risk of cardiovascular disease in humans (relative risk reductions ranging from 12% to 22%).

    “higher flavanone intake was associated with a lower risk of cardiovascular disease (relative risk reductions ranging from 12% to 22%)”

    Review

    Flavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies

    Epidemiologia (Basel, Switzerland)

More on Cardiovascular disease

Depression

downin humans1HR 0.84

1 study
  1. Flavanones are linked with a lower risk of depression in humans (HR 0.84 (95% CI 0.95 to 0.94 as written)).

    “with HRs (95% CIs) for quintile 5 vs. corresponding quintile being 0.63 (0.55 to 0.71) and 0.84 (0.95 to 0.94)”

    Humansquintile 5 vs corresponding quintile; linear association; interval as written in abstract, inconsistent with point estimatemedian 10.5 yearsn = 114,848

    Association of Dietary Flavonoid Intake with Incident Depression Risk and Brain Structural Changes: A Prospective Study in the UK Biobank

    medRxivPreprint

More on Depression

Osteoporosis

downin humans1OR 0.66

1 study
  1. Flavanones are associated with osteoporosis in humans (Q5 vs. Q1 OR 0.66, 95% CI 0.45–0.97).

    “The intake of flavones, isoflavones, and flavanones was beneficially associated with osteoporosis”

    Humanshighest versus lowest intake quintilen = 10,480

    Intake of dietary flavonoids in relation to bone loss among U.S. adults: a promising strategy for improving bone health

    Food & function

More on Osteoporosis

Augmentation index

downin humans1

1 study
  1. Flavanones are associated with augmentation index in humans (healthy non-smokers) (-0.93 %, 95 % CI -1.77, -0.09).

    “each sd/d higher intake of flavanones ((sd 19·5) mg/d) was associated with ~1 % lower cAIx (-0·93 %, 95 % CI -1·77, -0·09)”

    Humanshealthy non-smokerseach sd/d higher intake ((sd 19.5) mg/d)n = 381

    Higher habitual dietary flavonoid intake associates with lower central blood pressure and arterial stiffness in healthy older adults

    The British journal of nutrition

More on Augmentation index

Erectile dysfunction incidence

downin humans1RR 0.89

1 study
  1. Flavanones are associated with erectile dysfunction incidence in humans (multivariate-adjusted analysis) (RR 0.89, 95% CI 0.83–0.95).

    “a higher intake of flavanones, anthocyanins, and flavones was significantly associated with a reduction in risk of ED”

    Humansmultivariate-adjusted analysisextreme intakes compared10 yearsmalesn = 25,096

    Dietary flavonoid intake and incidence of erectile dysfunction

    The American journal of clinical nutrition

More on Erectile dysfunction incidence

Incident diabetes

downin humans1HR 0.69

1 study
  1. Flavanones are associated with incident diabetes in humans (Free of diabetes at baseline; high cardiovascular disease risk) (HR 0.69, 95% CI 0.49–0.97; P-trend = 0.03).

    “flavanones (HR: 0.69; 95% CI: 0.49, 0.97; P-trend = 0.03)”

    HumansFree of diabetes at baseline; high cardiovascular disease riskMean follow-up of 5.51 yearsmen and womensn = 3,430

    Intake of Total Polyphenols and Some Classes of Polyphenols Is Inversely Associated with Diabetes in Elderly People at High Cardiovascular Disease Risk

    The Journal of nutrition

More on Incident diabetes

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    A human study links flavanones with cognitive function; reviews describe lower stroke and cardiovascular disease risk and lower systolic blood pressure. Research spans 2 independent labs in 2 countries, but direct human results come from a single group. The European Commission and HORIZON EUROPE are each named as funders on 3 findings.

  2. Summary written from the findings.

Latest

Dec 2025: 0Jan 2026: 2Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 2Sep 2026: 1Oct 2026: 0Nov 2026: 07 papers in 12 months

See all 23 papers on flavanones